Looking beyond anti-TNF in IBD: Vedolizumab, tofacitinib, etc.
This item was part of the Therapy update: Best use of biologics in IBD in 2014 session at UEG Week 2014
You may be interested in:
English, Clinical aspects, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
UEG Week Pathway
- Intestinal & Motility